Annual Drug Patent Expirations for ZYTIGA
Zytiga is a drug marketed by Janssen Biotech and is included in one NDA. It is available from one supplier. There is one patent protecting this drug and two Paragraph IV challenges.
Drug patent litigation for ZYTIGA.
This drug has thirty-four patent family members in nineteen countries.
The generic ingredient in ZYTIGA is abiraterone acetate. One supplier is listed for this compound. Additional details are available on the abiraterone acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
